Obesity and age-related alterations in the gene expression of zinc-transporter proteins in the human brain

Translational Psychiatry

Volumn 6, Issue 6, 2016, Pages

  Olesen, R H ^a   Hyde, T M ^b,c   Kleinman, J E ^b   Smidt, K ^a   Rungby, J ^a,d   Larsen, A ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b Lieber Institute for Brain Development Johns Hopkins Medical Campus   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CATION TRANSPORT PROTEIN; DNA BINDING PROTEIN; MESSENGER RNA; SIGNAL PEPTIDE; SLC30A3 PROTEIN, HUMAN; SLC30A4 PROTEIN, HUMAN; SLC39A1 PROTEIN, HUMAN; SLC39A13 PROTEIN, HUMAN; SLC39A9 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MTF-1; ZINC; ZINC-BINDING PROTEIN;

ADULT; AFRICAN AMERICAN; AGE; AGED; ALZHEIMER DISEASE; BODY MASS; CAUCASIAN; COMPARATIVE STUDY; COMPLICATION; FEMALE; FRONTAL LOBE; GENE EXPRESSION; GENETIC DATABASE; GENETICS; HOMEOSTASIS; HUMAN; METABOLISM; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; STATISTICS; VERY ELDERLY;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BODY MASS INDEX; CARRIER PROTEINS; CATION TRANSPORT PROTEINS; DATABASES, GENETIC; DNA-BINDING PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRONTAL LOBE; GENE EXPRESSION; HOMEOSTASIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; OBESITY; RISK FACTORS; RNA, MESSENGER; STATISTICS AS TOPIC; TRANSCRIPTION FACTORS; ZINC;

EID: 85027481133     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/TP.2016.83     Document Type: Article

References (68)

1. WHO. On Ageing and Life Course. Available at http://www.who.int/ageing/about/facts/en/index.html. Accessed on 20 August 2013.
2. Alzheimer's Association. 2013 Alzheimer's disease facts and figures. Alzheimers Dement 2013; 9: 208-245.
3. WHO. Dementia: A Public Health Priority, 2012; ISBN: 978 92 4 156445 8.
4. Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y et al. Insulin resistance is associated with the pathology of Alzheimer disease: The Hisayama Study. Neurology 2010; 75: 764-770.
5. Panza F, Frisardi V, Capurso C, Imbimbo BP, Vendemiale G, Santamato A et al. Metabolic syndrome and cognitive impairment: Current epidemiology and pos¬sible underlying mechanisms. J Alzheimers Dis 2010; 21: 691-724.
6. Wotton CJ, Goldacre MJ. Age at obesity and association with subsequent dementia: Record linkage study. Postgrad Med J 2014; 90: 547-551.
7. Tolppanen AM, Ngandu T, Kareholt I, Laatikainen T, Rusanen M, Soininen H et al. Midlife and late-life body mass index and late-life dementia: Results from a pro¬spective population-based cohort. J Alzheimers Dis 2014; 38: 201-209.
8. Xu WL, Atti AR, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Midlife over¬weight and obesity increase late-life dementia risk: A population-based twin study. Neurology 2011; 76: 1568-1574.
9. Gunstad J, Paul RH, Cohen RA, Tate DF, Gordon E. Obesity is associated with memory deficits in young and middle-aged adults. Eat Weight Disord 2006; 11: E15-e19.
10. Gunstad J, Paul RH, Cohen RA, Tate DF, Spitznagel MB, Gordon E. Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr Psychiatry 2007; 48: 57-61.
11. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Yaffe K. Obesity in middle age and future risk of dementia: A 27 year longitudinal population based study. BMJ 2005; 330: 1360.
12. WHO. WHO Factsheet. Available at http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed on 20 August 2015.
13. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ et al. National, regional, and global trends in body-mass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 91 million participants. Lancet 377: 557-567.
14. de Luis DA, Pacheco D, Izaola O, Terroba MC, Cuellar L, Cabezas G. Micronutrient status in morbidly obese women before bariatric surgery. Surg Obes Relat Dis 2013; 9: 323-327.
15. Suliburska J, Cofta S, Gajewska E, Kalmus G, Sobieska M, Samborski W et al. The evaluation of selected serum mineral concentrations and their association with insulin resistance in obese adolescents. Eur Rev Med Pharmacol Sci 2013; 17: 2396-2400.
16. Garcia OP, Long KZ, Rosado JL. Impact of micronutrient deficiencies on obesity. Nutr Rev 2009; 67: 559-572.
17. Costarelli L, Muti E, Malavolta M, Cipriano C, Giacconi R, Tesei S et al. Distinctive modulation of inflammatory and metabolic parameters in relation to zinc nutri¬tional status in adult overweight/obese subjects. J Nutr Biochem 2010; 21: 432-437.
18. Beletate V, El Dib R, Atallah A. Zinc supplementation for the prevention of type 2 diabetes mellitus. Cochrane Database Syst Rev 2007.
19. Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004; 63: 1187-1192.
20. Xu WL, von Strauss E, Qiu CX, Winblad B, Fratiglioni L. Uncontrolled diabetes increases the risk of Alzheimer's disease: A population-based cohort study. Dia- betologia 2009; 52: 1031-1039.
21. Frederickson CJ, Suh SW, Silva D, Frederickson CJ, Thompson RB. Importance of zinc in the central nervous system: The zinc-containing neuron. J Nutr 2000; 130: 1471S-1483S.
22. Stoltenberg M, Bush AI, Bach G, Smidt K, Larsen A, Rungby J et al. Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency. Neuroscience 2007; 150: 357-369.
23. Danscher G, Jensen KB, Frederickson CJ, Kemp K, Andreasen A, Juhl S et al. Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: A proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material. J Neurosci Methods 1997; 76: 53-59.
24. Religa D, Strozyk D, Cherny RA, Volitakis I, Haroutunian V, Winblad B et al. Elevated cortical zinc in Alzheimer disease. Neurology 2006; 67: 69-75.
25. Wenstrup D, Ehmann WD, Markesbery WR. Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains. Brain Res 1990; 533: 125-131.
26. Panayi AE, Spyrou NM, Iversen BS, White MA. Part P. Determination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass spectrometry. J Neurol Sci 2002; 195: 1-10.
27. Lyubartseva G, Lovell MA. A potential role for zinc alterations in the pathogenesis of Alzheimer's disease. Biofactors 2012; 38: 98-106.
28. Linkous DH, Flinn JM, Koh JY, Lanzirotti A, Bertsch PM, Jones BF et al. Evidence that the ZNT3 protein controls the total amount of elemental zinc in synaptic vesicles. J Histochem Cytochem 2008; 56: 3-6.
29. Beyer N, Coulson DT, Heggarty S, Ravid R, Hellemans J, Irvine GB et al. Zinc transporter mRNA levels in Alzheimer's disease postmortem brain. JAlzheimers Dis 2012; 29: 863-873.
30. Adlard PA, Parncutt JM, Finkelstein DI, Bush AI. Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory deficits of Alzheimer's disease? J Neurosci 2010; 30: 1631-1636.
31. Vergnano AM, Rebola N, Savtchenko LP, Pinheiro PS, Casado M, Kieffer BL et al. Zinc dynamics and action at excitatory synapses. Neuron 2014; 82: 1101-1114.
32. Sandstead HH. Subclinical zinc deficiency impairs human brain function. J Trace Elem Med Biol 2012; 26: 70-73.
33. Lee JY, Cole TB, Palmiter RD, Suh SW, Koh JY. Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci USA 2002; 99: 7705-7710.
34. Linkous DH, Adlard PA, Wanschura PB, Conko KM, Flinn JM. The effects of enhanced zinc on spatial memory and plaque formation in transgenic mice. JAlzheimers Dis 2009; 18: 565-579.
35. Craddock TJ, Tuszynski JA, Chopra D, Casey N, Goldstein LE, Hameroff SR et al. The zinc dyshomeostasis hypothesis of Alzheimer's disease. PLoS One 2012; 7: E33552.
36. Szewczyk B. Zinc homeostasis and neurodegenerative disorders. Front Aging Neurosci 2013; 5: 33.
37. Smith JL, Xiong S, Markesbery WR, Lovell MA. Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain. Neuroscience 2006; 140: 879-888.
38. Lovell MA, Smith JL, Xiong S, Markesbery WR. Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease. Neurotox Res 2005; 7: 265-271.
39. Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011; 478: 519-523.
40. Bosomworth HJ, Adlard PA, Ford D, Valentine RA. Altered expression of ZnT10 in Alzheimer's disease brain. PLoS One 2013; 8: E65475.
41. Kennedy ML, Failla ML. Zinc metabolism in genetically obese (ob/ob) mice. J Nutr 1987; 117: 886-893.
42. Fernandez-Lopez JA, Esteve M, Rafecas I, Remesar X, Alemany M. Management of dietary essential metals (iron, copper, zinc, chromium and manganese) by Wistar and Zucker obese rats fed a self-selected high-energy diet. Biometals 1994; 7: 117-129.
43. Chen MD, Lin PY, Cheng V, Lin WH. Zinc supplementation aggravates body fat accumulation in genetically obese mice and dietary-obese mice. Biol Trace Elem Res 1996; 52: 125-132.
44. Kennedy ML, Failla ML, Smith JC Jr.. Influence of genetic obesity on tissue con-centrations of zinc, copper, manganese and iron in mice. J Nutr 1986; 116: 1432-1441.
45. Takeda A, Nakamura M, Fujii H, Tamano H. Synaptic Zn(2+) homeostasis and its significance. Metallomics 2013; 5: 417-423.
46. Takeda A. Zinc signaling in the hippocampus and its relation to pathogenesis of depression. Mol Neurobiol 2011; 44: 166-174.
47. Takeda A, Tamano H. Insight into zinc signaling from dietary zinc deficiency. Brain Res Rev 2009; 62: 33-44.
48. Massaro TF, Mohs M, Fosmire G. Effects of moderate zinc deficiency on cognitive performance in young adult rats. Physiol Behav 1982; 29: 117-121.
49. Solati Z, Jazayeri S, Tehrani-Doost M, Mahmoodianfard S, Gohari MR. Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: A double-blind, randomized, placebo-controlled trial. Nutr Neurosci 2015; 18: 162-168.
50. Nowak G, Legutko B, Szewczyk B, Papp M, Sanak M, Pilc A. Zinc treatment induces cortical brain-derived neurotrophic factor gene expression. Eur J Pharmacol 2004; 492: 57-59.
51. Franco JL, Posser T, Brocardo PS, Trevisan R, Uliano-Silva M, Gabilan NH et al. Involvement of glutathione, ERK1/2 phosphorylation and BDNF expression in the antidepressant-like effect of zinc in rats. Behav Brain Res 2008; 188: 316-323.
52. Sowa-Kucma M, Legutko B, Szewczyk B, Novak K, Znojek P, Poleszak E et al. Antidepressant-like activity of zinc: Further behavioral and molecular evidence. J Neural Transm 2008; 115: 1621-1628.
53. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997; 18: 351-357.
54. Mellone M, Pelucchi S, Alberti L, Genazzani AA, Di Luca M, Gardoni F. Zinc transporter-1: A novel NMDA receptor-binding protein at the postsynaptic den¬sity. J Neurochem 2015; 132: 159-168.
55. Sobieszczanska M, Tubek S, Szygula R, Bunio A. Is the zinc neuroprotective effect caused by prevention of intracellular zinc accumulation? Adv Clin Exp Med 2012; 21: 245-248.
56. Capasso M, Jeng JM, Malavolta M, Mocchegiani E, Sensi SL. Zinc dyshomeostasis: A key modulator of neuronal injury. J Alzheimers Dis 2005; 8: 93-108
57. Untergasser G, Rumpold H, Plas E, Witkowski M, Pfister G, Berger P. High levels of zinc ions induce loss of mitochondrial potential and degradation of antiapoptotic Bcl-2 protein in in vitro cultivated human prostate epithelial cells. Biochem Biophys Res Commun 2000; 279: 607-614.
58. Sensi SL, Rapposelli IG, Frazzini V, Mascetra N. Altered oxidant-mediated intra¬neuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease. Exp Gerontol 2008; 43: 488-492.
59. Hamatake M, Iguchi K, Hirano K, Ishida R. Zinc induces mixed types of cell death, necrosis, and apoptosis, in molt-4 cells. J Biochem 2000; 128: 933-939.
60. Saito T, Takahashi K, Nakagawa N, Hosokawa T, Kurasaki M, Yamanoshita O et al. Deficiencies of hippocampal Zn and ZnT3 accelerate brain aging of Rat. Biochem Biophys Res Commun 2000; 279: 505-511.
61. Patrushev N, Seidel-Rogol B, Salazar G. Angiotensin II requires zinc and down- regulation of the zinc transporters ZnT3 and ZnT10 to induce senescence of vascular smooth muscle cells. PLoS One 2012; 7: E33211.
62. Jeong J, Eide DJ. The SLC39 family of zinc transporters. Mol Aspects Med 2013; 34: 612-619.
63. Qian J, Xu K, Yoo J, Chen TT, Andrews G, Noebels JL. Knockout of Zn transporters Zip-1 and Zip-3 attenuates seizure-induced CA1 neurodegeneration. J Neurosci 2011; 31: 97-104.
64. Wang F, Dufner-Beattie J, Kim BE, Petris MJ, Andrews G, Eide DJ. Zinc-stimulated endocytosis controls activity of the mouse ZIP1 and ZIP3 zinc uptake transporters. J Biol Chem 2004; 279: 24631-24639.
65. Berg AH, Rice CD, Rahman MS, Dong J, Thomas P. Identification and characterization of membrane androgen receptors in the ZIP9 zinc transporter subfamily: I. Discovery in female atlantic croaker and evidence ZIP9 mediates testosterone-induced apoptosis of ovarian follicle cells. Endocrinology 2014; 155: 4237-4249.
66. Taniguchi M, Fukunaka A, Hagihara M, Watanabe K, Kamino S, Kambe T et al. Essential role of the zinc transporter ZIP9/SLC39A9 in regulating the activations of Akt and Erk in B-cell receptor signaling pathway in DT40 cells. PLoS One 2013; 8: E58022.
67. Leung KW, Liu M, Xu X, Seiler MJ, Barnstable CJ, Tombran-Tink J. Expression of ZnT and ZIP zinc transporters in the human RPE and their regulation by neurotrophic factors. Invest Ophthalmol Vis Sci 2008; 49: 1221-1231.
68. Kowalska K, Bizon A, Zalewska M, Milnerowicz H. The influence of biological and environmental factors on metallothionein concentration in the blood. J Trace Elem Med Biol 2015; 29: 99-103.